Cirrhosis/Liver Failure News

The FDA cleared an investigational new drug application for LYG-LIV0001, an allogeneic hepatocyte transplantation solution for end-stage liver disease, according to the agent’s manufacturer.

Bedside measures including activity, quality of life and physical function accurately predicted the risk for overt hepatic encephalopathy in patients with cirrhosis, according to results published in The American Journal of Gastroenterology.

New data indicate that circulating microRNAs may increased risk for hepatocellular carcinoma among patients with chronic hepatitis C-related cirrhosis and a sustained virologic response.

In this exclusive video, Andrew Allegretti, MD, MSc, discusses his poster from The Liver Meeting Digital Experience that explored factors associated with response to terlipressin treatment in patients with hepatorenal syndrome.

Ursodeoxycholic acid treatment correlated with reduced mortality, need for liver transplantation and biliary tract cancer in patients with primary sclerosing cholangitis, according to a presenter at The Liver Meeting Digital Experience.

Using genetic markers with metabolic risk factors can predict an individual patient’s risk for developing liver related events due to non-alcoholic fatty liver disease, according to a researcher at The Liver Meeting Digital Experience.

Visceral adipose tissue with low liver fat increased the risk for a coronary heart disease event, according to a presenter at The Liver Meeting Digital Experience.

Investigators observed higher rates of morbidity and mortality in patients with chronic liver disease with COVID-19, according to a presenter at The Liver Meeting Digital Experience.

Despite guidelines to ensure proper screening, one study presented during the Liver Meeting Digital Experience showed only 42% of infants born to women with hepatitis C and cirrhosis are screened and followed for hepatitis C.

In decompensated liver cirrhosis, long-term responders with water retention treated with tolvaptan without recurrence experienced significantly better prognosis, according to study results.